ArticleJournal of clinical lipidology
Remnant cholesterol and associations with incidence, progression, and change in coronary artery calcium in South Asian Americans.
Article in Journal of clinical lipidology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRemnant cholesterol (RC) may contribute to residual risk of atherosclerotic cardiovascular disease (ASCVD), but few studies have examined this in South Asian populations, who experience a disproportionately high incidence of ASCVD.
objectiveUsing data from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study, a community-based longitudinal cohort of South Asian men and women without ASCVD at baseline, we examined the association between RC and change in coronary artery calcium (CAC).
methodsBaseline fasting blood specimens and questionnaires were obtained between 2010-2013. CAC was assessed both at baseline and after 5-year follow-up in 698 participants. We used multivariable linear and logistic regression to examine relationships between RC quartile and CAC incidence (no CAC at baseline to any CAC at examination 2), CAC progression, and overall change in CAC.
resultsIn 892 MASALA study participants at baseline, mean RC was 25.8 ± 11.8 mg/dL. Incident CAC occurred in 25.8% of participants and increased across RC quartiles (P = .002). After covariate adjustment, individuals with RC levels in the third (odds ratio [OR]: 2.24, 95% CI: 1.01-4.98) and fourth quartiles (OR: 2.57, 95% CI: 1.20-5.51) had significantly higher odds of incident CAC after 5 years than those in the lowest RC quartile. These associations persisted after sequential adjustment for behaviors, adiposity, and measures of insulin sensitivity and did not vary by gender. RC quartiles were not associated with CAC progression or CAC change.
conclusionHigher RC levels were associated with increased odds of incident CAC independent of risk factors for ASCVD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.